Literature DB >> 33529910

Fibroblast-like synoviocytes in rheumatoid arthritis: Surface markers and phenotypes.

Zewen Wu1, Dan Ma2, Helin Yang3, Jinfang Gao4, Gailian Zhang5, Ke Xu6, Liyun Zhang7.   

Abstract

Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that mainly affects synovial joints. During the course of RA, the synovium transforms into hyperplastic invasive tissue, leading to cartilage and bone destruction. Fibroblast-like synoviocytes (FLS) in the synovial lining develop aggressive phenotypes and produce pathogenic mediators that lead to the occurrence and progression of disease, playing a major role in RA pathophysiology. Therefore, research on FLS has become the main focus within the RA field. With technical advances and the development of multi-omics comprehensive analysis approaches, it has become possible to identify different FLS subsets via high-throughput sequencing and investigate differences between FLS phenotypes, allowing for the detailed study of RA pathogenesis. This review summarizes recent works on FLS subtypes and the surface marker proteins identified for different subtypes, providing a theoretical basis and reference for future studies on FLS in RA. The current work also addresses the clinical potential of FLS surface markers in RA based on related research from other fields.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Fibroblast-like synoviocyte; Rheumatoid arthritis; Surface marker

Mesh:

Year:  2021        PMID: 33529910     DOI: 10.1016/j.intimp.2021.107392

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  10 in total

1.  Fascin1 mediated release of pro-inflammatory cytokines and invasion/migration in rheumatoid arthritis via the STAT3 pathway.

Authors:  Kun Ma; Chuan Zhang; Wuyin Li
Journal:  Cell Cycle       Date:  2021-09-09       Impact factor: 5.173

Review 2.  Synovial single-cell heterogeneity, zonation and interactions: a patchwork of effectors in arthritis.

Authors:  Barbora Schonfeldova; Kristina Zec; Irina A Udalova
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.580

3.  Addition of Fibroblast-Stromal Cell Markers to Immune Synovium Pathotypes Better Predicts Radiographic Progression at 1 Year in Active Rheumatoid Arthritis.

Authors:  Xue-Pei Zhang; Jian-Da Ma; Ying-Qian Mo; Jun Jing; Dong-Hui Zheng; Le-Feng Chen; Tao Wu; Chu-Tao Chen; Qian Zhang; Yao-Yao Zou; Jian-Zi Lin; Yan-Hui Xu; Yao-Wei Zou; Ze-Hong Yang; Li Ling; Pierre Miossec; Lie Dai
Journal:  Front Immunol       Date:  2021-11-23       Impact factor: 7.561

4.  Umbelliferone and scopoletin target tyrosine kinases on fibroblast-like synoviocytes to block NF-κB signaling to combat rheumatoid arthritis.

Authors:  Qilei Chen; Wenmin Zhou; Yueming Huang; Yuanyang Tian; Sum Yi Wong; Wing Ki Lam; Ka Yee Ying; Jianye Zhang; Hubiao Chen
Journal:  Front Pharmacol       Date:  2022-07-25       Impact factor: 5.988

5.  Galangin alleviates rheumatoid arthritis in rats by downregulating the phosphatidylinositol 3-kinase/protein kinase B signaling pathway.

Authors:  Xiongwei Deng; Hailang Le; Taohong Wan; Meizhi Weng; Yongzhen Tan
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

6.  Imperatorin Inhibits Proliferation, Migration, and Inflammation via Blocking the NF-κB and MAPK Pathways in Rheumatoid Fibroblast-like Synoviocytes.

Authors:  Wei Lin; Gang Chen; Yuhang Mao; Xuemei Ma; Junnan Zhou; Xiaolu Yu; Chaoliang Wang; Mei Liu
Journal:  ACS Omega       Date:  2022-08-16

7.  Assessment of disease activity in patients with rheumatoid arthritis using plasma tumour M2-pyruvate kinase test.

Authors:  Sung Soo Ahn; Hye Min Kim; Younhee Park
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

Review 8.  Role of the hedgehog signaling pathway in rheumatic diseases: An overview.

Authors:  Yazhen Su; Hao Xing; Jie Kang; Linkun Bai; Liyun Zhang
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

9.  FOXC1‑mediated TRIM22 regulates the excessive proliferation and inflammation of fibroblast‑like synoviocytes in rheumatoid arthritis via NF‑κB signaling pathway.

Authors:  Yazhi Wei; Xinmin Huang; Yanmei Ma; Liping Dai
Journal:  Mol Med Rep       Date:  2022-08-10       Impact factor: 3.423

10.  Myrtenal and β-caryophyllene oxide screened from Liquidambaris Fructus suppress NLRP3 inflammasome components in rheumatoid arthritis.

Authors:  Wen-Xuan Li; Ping Qian; Yi-Tong Guo; Li Gu; Jessore Jurat; Yang Bai; Dong-Fang Zhang
Journal:  BMC Complement Med Ther       Date:  2021-09-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.